BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, Ratings reports. The brokerage issued an outperform ...

Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...

Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Outperform ...

In a report released today, Kevin O’Halloran from BMO Capital maintained a Buy rating on Hochschild Mining (HOC – Research Report), with a ...

BMO Capital upgraded Goeasy (EHMEF) to Outperform from Market Perform with a price target of C$200, down from C$207. Goeasy trades at trough ...

Stock market corrections of 10% hurt. But research shows that they often don't portend worse things ahead for stocks.

The revised estimates put Wall Street's average year-end target for the S&P 500 at 6,607, implying an advance of more than 17% from Friday's close of 5,638.94, according to a recent survey of Wall ...

The Federal Reserve will keep interest rates steady through the first half of the year, before delivering two reductions ...

Evertz Technologies (TSE:ET – Free Report) had its price target reduced by BMO Capital Markets from C$15.00 to C$13.50 in a research report report published on Thursday,BayStreet.CA reports.

Canadian Pacific Kansas City Limited (TSX: CP) (NYSE: CP) ("CPKC") announced that its wholly-owned subsidiary, Canadian ...

The Federal Reserve is still expected to cut interest rates this year — but not until the fall — as policymakers weigh the fallout from President Trump’s tariffs on trade ...

ECN Capital Corp. (TSX: ECN) ("ECN Capital” or the "Company”) today announced that it has entered into an agreement with a syndicate of underwriters (the "Underwriters”) led by CIBC Capital Markets, ...